期刊文献+

强生Vitros 350生化分析仪验收及性能的综合评价 被引量:16

Vitros 350 biochemical analyzer acceptance and demonstration of the comprehensive evaluation
下载PDF
导出
摘要 目的对强生Vitros350生化分析仪验收及性能进行综合评价。方法依据ISO/15189对实验室质量和能力的要求对强生Vitros350生化分析仪进行验收。参照临床实验室标准化协会的EP6-A、EP9-A2文件和强生公司提供的性能评价方案,对21项生化指标的准确度、精密度、临床参考区间和线性范围进行验证,与BeckmanLX-20生化分析仪进行相关性比较,并用Westgard标准决定图描述实验系统误差。结果 21项生化指标的准确度、精密度、线性范围和正常参考区间均符合厂商说明;K和Na在Level1水平的Westgard标准决定图中处于良好操作点,其余各项和Level2所有项目均在优秀操作点;与BeckmanLX-20生化分析仪进行相关性比较,除CK-MB(Y=0.8317X-2.8822,r=0.850)和Bc(Y=0.7619X-4.1093,r=0.913)不呈线性相关外,K、Na、Cl、Glu、Urea、Cre、Uric、ALT、TP、Alb、TBil、AST、CK、TC和TG均呈线性相关(r>0.975)。以Statland医学决定水平(Xc)判断临床可接受性,ALT和Urea在Xc1处不可接受,但无临床意义;TP在Xc1处不可接受,可经过强生Vitros350的斜率和截距进行调整;TBil差异较大,考虑到方法学的因素,暂时以强生Vitros350为基准。结论强生Vitros350生化分析仪已通过系统的验收和验证。 Objective To evaluate the acceptance of the John&John Vitros 350 assay system. Methods Based on laboratory quality and competence requirements of the ISO/15189 to evaluate the Vitros 350 biochemistry analyzer. According to CLSI's EP6- A,EP9-A2,and John&John corporation demonstration project to demonstrate for potassmm(K) and other 21 items of the accura ey, reliability, linear range and clinical reference,and compared with Beckman LX-20 analyzer, and use Westgard method evaluation decision chart to describe the systematic errors. Results 21 items of the accuracy, reliability, linear range and clinical reference ac- corded all with the declaration of the corporation; K and sodium(Na) in the Level 1 decision diagram Westgard standards in good operating point,all items remaining and Le:cel 2 are in excellent operating point. Compared with,the Beckman LX-20 analyzer, except CK MB(Y=0. 831 7X=2. 882 2,r=0. 850) and Bc(Y:0. 761 9X=4. 109 3,r=0. 913) is not linearly related to external,K,Na, C1,Glu,Urea,Cre,Urie,ALT, TP, Alb, TBil, AST,CK,TC and TG of the values are 〉0. 975. To judge the clinical acceptability with the level of Statland Medicine(Xc), ALT and Urea in the Xcl unacceptable, but no clinical significance. TP in the Xcl unac ceptable and through adjust the slope and intercept acception. TBil difference Significantly,think methodology over, use Vitros 350 as the benchmark. Conclusion The function of Vitros 350 is accorded to the requirements of acceptance and demonstration for quality assurance for laboratories.
出处 《国际检验医学杂志》 CAS 2011年第1期3-5,8,共4页 International Journal of Laboratory Medicine
关键词 评价研究 验收 性能验证 acceptance performance demonstration evaluation
  • 相关文献

参考文献16

  • 1中国合格评定国家认可委员会.CNAS-CL02医学实验室质量和能力认可准则(ISO15189:2003)[M].北京:中国计量出版社,2006:1-43.
  • 2VITROS system verification[S].Ortho-clinical Diagnotics,USA.2004.
  • 3National Committee for Clinical Laboratory Standards.Evaluation of the linearity of quantitative measurement procedures:a statistical approach,approved guideline[S].Wayne,PA:EP6-A.NCCLS.2003.
  • 4National Committee for Clinical Laboratory Standards.Method comparison and bias estimation using patient samples[S].Approved Guideline,2nd ed,EP9-A2,2002.
  • 5U.S.Department of Health and Human Services.Medicare,medicaid and CLIA programs;Regulations implementing the clinical laboratory improvement amendments of 1998(CLIA)[S].
  • 6U.S.Department of Health and Human Services.42 CFR Part 493:medicare,medicaid and CLIA programs;Laboratory requirements relating to quality systems and certain personnel qualifications;Final rule[J].Federal Register,2003,68:3640-3714.
  • 7张心菊,吴炯,郭玮,潘柏申.强生Vitros 950生化检测系统性能验证[J].检验医学,2006,21(6):564-569. 被引量:8
  • 8李文娟.强生Vitros350生化检测系统性能验证.新医学学刊,2008,5(12):2089-2090.
  • 9林有东,蔡鹏威.VITROS 250全自动干化学分析仪的评价[J].福建医药杂志,2006,28(6):116-117. 被引量:12
  • 10Westgard JO.A method evaluation decision chart(MEDx Chart) for judging method performance[J].Clin Lab Sci,1995,8:277-283.

二级参考文献37

  • 1刘小娟,黄亨建,李萍,徐克和,余霆,胥劲,叶艾竹,吴士吉.罗氏生化试剂用于奥林巴斯全自动生化分析仪的溯源性分析[J].华西医学,2004,19(3):401-402. 被引量:16
  • 2屈引婷,王鸿.两种不同方法检测血清肌酐结果的比较[J].现代检验医学杂志,2005,20(4):82-82. 被引量:7
  • 3徐国宾,吴南,王清涛.要重视血清酶学测定的标准化工作[J].临床检验杂志,2007,25(3):161-164. 被引量:25
  • 4Burtis CA, Ashwood E. Tietz textbook of clinical chemistry. 3rd ed, W.B. Saunders Company : Philadelphia, 1999:657-666.
  • 5韩志均,黄志锋,卢业成,等.临床化学常用项目自动分析法.沈阳:辽宁科学技术出版社,2005.
  • 6Ennor AH, Rosenberg H. Some proterties of creatine phosphokinase. Biochem J, 195d, 57: 203-212.
  • 7Hughes BP. A method for the estimation of serum creatine kinase and its use in comparing crcatine kinase and aldolase activity in normal and pathological sera. Clin Chim Acta, 1962, 7: 597- 603.
  • 8Armstrong JB, Lowden JA, Sherwin AL. Automated fluorometric creatine kinase assay. Measurement of 100-fold normal activity without serum dilution. Clin Chem,1974, 20: 560-565.
  • 9Lundin A, Jaderlund B, Lovgren T. Optimized bioluminescence assay of creatine kinase and creatine kinase B-subunit activity. Clin Chem, 1982,28: 609-614.
  • 10Tarkkanen P, Komor S, Comely C, et al. Bioluminescence assay of creatine kinase and its isoenzymes in serum and eerebrospinal fluid. Clin Chem, 1979,25 : 1644-1648.

共引文献89

同被引文献124

引证文献16

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部